Cencora, Inc. announced on December 12, 2025, that it will acquire a majority of OneOncology for approximately $3.6 billion and retire $1.3 billion in debt, totaling around $5.0 billion, funded by $4.5 billion in bridge financing commitments. The transaction awaits regulatory approval.